Euronews ...

After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond ...

Ayub Savula: Blow to DAP-K as deputy party leader defects to Ruto's UDA This little-known island in the Indian Ocean is a ...

BioSpace, the leading life sciences news and careers site, has announced its 2026 selections for the industry's most promising up-and-coming companies.

On Eli Lilly, UBS struck a more constructive tone, assuming coverage at Buy with a $1,250 price target. Analysts said Lilly is “the best growth story for 2026–2030” in large-cap pharma, driven by ...

The immune system’s first encounter with a virus or vaccine establishes a “starting template” that shapes its response to new ...

Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on ...

The problem with drug patents is that they end, leading to patent cliffs. That's when cheaper generic versions of a drug take ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for ...

Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson ...

Dr. Mahadevan discusses newly issued GCC guidance developed to improve the management of pregnancy for patients with IBD.

In early December, a Centers for Disease Control and Prevention advisory committee ended the long-standing recommendation that every newborn receive a hepatitis B vaccine within 24 hours of birth, ...